The Scholz Group

Dr. Hanne Scholz is senior scientist at the Department of Transplantation Medicine at the Oslo University Hospital (OUS), and the director of the human islet isolation facility producing clinical approved pancreatic insulin-producing for treatment of type 1 diabetes in Norway. Scholz is the project leader of “Oslo Regenerative Medicine Initiative”, a focus research area appointed by OUS.  The Scholz research group is devoted to improving and optimizing islet isolation, transplantation and clinical outcome of beta cell replacement therapy. A recent research focus is developing a stem cell based cellular therapy for diabetes and developing a functional mini-pancreas for the "organ on a chip" platform.

Selected Publications

Published Feb. 19, 2018 11:17 AM - Last modified Apr. 23, 2019 2:31 PM